Saturday, May 18, 2024

Stay in the loop with our latest updates! Subscribe now to receive exclusive news, insights, and offers delivered straight to your inbox. Don’t miss out on the latest trends and developments – subscribe today!

HomeInvestingJim Cramer's latest thoughts on 4 portfolio names including a 'coiled spring'

Jim Cramer’s latest thoughts on 4 portfolio names including a ‘coiled spring’

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Market talk: The S & P 500 continues to trade in a tight range Tuesday, with no significant budge in either direction. It’s similar to the action we’ve seen over the past several trading sessions. In four of the past five sessions, the S & P 500 has not closed more than 0.16% in a positive or negative direction; Friday’s 0.51% gain is the lone exception. Tuesday’s subdued action follows a noisy wholesale inflation report before the bell. The producer price index for April increased a more-than-expected 0.5% month over month. However, downward revisions to the March report make it more difficult to interpret the April numbers than usual. All eyes will be on the consumer price index due out at 8:30 a.m. ET Wednesday. At an event in Amsterdam on Tuesday , Federal Reserve Chair Jerome Powell reiterated that the U.S. central bank is likely to keep interest rates steady for a while due to sticky inflation. Quick takeaways from an Analyst Conference: A couple of our companies spoke at Bank of America’s health-care conference Tuesday, including GE Healthcare . Most of the questions centered on the medical equipment maker’s ability to meet its full-year outlook — the same debate that caused the stock to fall more than 14% to $76 per share after earnings . We called that sell-off an overreaction, and the stock has climbed more than 5% since then, including Tuesday’s slight decline. CFO James Saccaro reiterated Tuesday that the fulfillment delay in its patient-care solutions business — among the reasons for the first-quarter miss — was a

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments

Translate »
×